Stine Emilie Weis-Banke

A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma

Julie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Evelina Martinenaite et al. · Nature Medicine · 2021 · 209 citations · Full text

Medicine, Immunology, Oncology +17

Arginase 1–Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti–PD-1 Checkpoint Blockade

Mia Aaboe Jørgensen, Stefano Ugel, Mie Linder Hübbe et al. · Cancer Immunology Research · 2021 · 61 citations · Full text

Medicine, Immunology, Oncology +17

Mutant FOXL2C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors

Stine Emilie Weis-Banke, Mads Lerdrup, Daniela Kleine‐Kohlbrecher et al. · Cancer Research · 2020 · 57 citations · Full text

Life Sciences, Genetics, Molecular Biology +11

Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms

Jacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Dahlager Jørgensen et al. · Frontiers in Oncology · 2021 · 55 citations · Full text

Medicine, Immunology, Oncology +17

TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer

Maria Perez-Penco, Stine Emilie Weis-Banke, Aimilia Schina et al. · Journal for ImmunoTherapy of Cancer · 2022 · 45 citations · Full text

Medicine, Immunology, Oncology +17